Indication
Hand
7 clinical trials
19 products
Clinical trial
Inactivated Bivalent Enterovirus Vaccine Phase I/II Clinical Trial: Open-Label Observation in Healthy Adults and Children, and Randomized, Double-Blind, Controlled Clinical Trial in ChildrenStatus: Recruiting, Estimated PCD: 2024-12-17
Clinical trial
Effectiveness and Safety of Inactivated EV71 Vaccine (Human Diploid Cell) in 6-71 Months Children: an Open-label Controlled Phase Ⅳ Clinical StudyStatus: Completed, Estimated PCD: 2017-12-01
Product
Inactivated EV71 vaccineClinical trial
A Phase I Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Adults, Children and InfantsStatus: Completed, Estimated PCD: 2011-06-01
Product
160EuProduct
320EuProduct
640Eu/0.5mlProduct
1280EuProduct
0EuProduct
320Eu/0.5mlProduct
1280Eu/0.5mlClinical trial
To Evaluate the Lot-to-lot Consistency of Immunogenicity, Safety, and Immune Persistence of Three Consecutive Commercial Manufacturing Batches of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell) in Children Aged 6-35 Months in a Randomized, Blinded StudyStatus: Recruiting, Estimated PCD: 2024-03-31
Product
EV71 VaccineClinical trial
Study on the Immunogenicity and Safety of Inactivated Enterovirus Type 71 Vaccine Combined Administration With Recombinant Hepatitis B and Group A Meningococcal VaccineStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
Enterovirus Type 71 VaccineClinical trial
Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and RevascularizationStatus: Recruiting, Estimated PCD: 2024-09-24
Product
ShamClinical trial
Use of EPs®7630 in Hand, Foot and Mouth DiseaseStatus: Completed, Estimated PCD: 2022-06-01
Product
EPs 7630